Use of AhR agonist for the preventive or curative treatment of metabolic syndrome and the associated disorders.

Bruno Lamas (1) , Harry Sokol (2) , Philippe Langella (2) , Jane Mea Natividad (2) , Mathias Lavie-Richard (2) , Marie-Laure Michel (2)

1 ToxAlim-ENTeRisk - Endocrinologie & Toxicologie de la Barrière Intestinale
2 MICALIS - MICrobiologie de l'ALImentation au Service de la Santé

Domaines: Sciences du Vivant [q-bio]

Bruno Lamas, Harry Sokol, Philippe Langella, Jane Mea Natividad, Mathias Lavie-Richard, et al.. Use of AhR agonist for the preventive or curative treatment of metabolic syndrome and the associated disorders.. France, Patent n° : EP16306300.1. 2016. ⟨hal-02795779⟩